- Details
- Description
-
Packaging Size1 Bottle/Box
-
Strength21mg/ml
-
CompositonTrastuzumab
-
TreatmentHER2+BreastCancer,HER2+StomachCancer,HER2+Non-smallCellLungCancer
-
FormPowder
-
BrandHANQUYOU (汉曲优)
-
Quantity Unit60mg/Bottle&150mg/Bottle
-
ManufacturerShanghai Henlius Biotech,China
HANQUYOU® (Trastuzumab) sold under the brand name 汉曲优® in china, Since its launch, 汉曲优® has been successfully approved for marketing in more than 40 countries and regions including China, the United Kingdom, France, Germany, Switzerland, Australia, Finland, Spain, Argentina, Saudi Arabia, and Singapore.
- America(USA) trade name: HERCESSI™
- European trade name: Zercepac®
- Australian trade names: Tuzucip® and Trastucip®
- ThaiLand trade name: TRAZHER®
- Philippine trade name: Hertumab®
Trastuzumab is a targeted cancer drug. It is a treatment for cancers that have large amounts of a protein called human epidermal growth factor receptor 2 (HER2) .